SlideShare a Scribd company logo
The 2nd Diabetes Attitudes,
Wishes & Needs (DAWN2) study:
objectives and methodology
Richard Holt
University of Southampton, UK
on behalf of the DAWN2 Study Group
Rachid Malek, Johan Wens, João Eduardo Salles, Katharina Kovacs Burns, Michael Vallis,
Xiaohui Guo, Ingrid Willaing, Gérard Reach, Norbert Hermanns, Bernhard Kulzer, Frans
Pouwer, Antonio Nicolucci, Marco Comaschi, Hitoshi Ishii, Miguel Escalante, Andrzej
Kokoszka, Alexandre Mayorov, Edelmiro Menendez, Ilhan Tarkun, Melanie Davies, Angus
Forbes, Neil Munro, Mark Peyrot, Søren Eik Skovlund, & Christine Mullan-Jensen
Richard Holt has acted as an advisory board member and
speaker for Novo Nordisk, and as a speaker, for Sanofi-
Aventis, Eli Lilly, Otsuka and Bristol-Myers Squibb. He has
received grants in support of investigator trials from Novo
Nordisk and has received funding for travel and
accommodation to attend DAWN2 International Publication
Planning Committee meetings and to attend this meeting
DAWN study in 2001
5426
Adults with diabetes
13
Countries
3982
Healthcare professionals
Platform for stakeholder dialogue and engagement
To improve outcomes in diabetes,
we must focus on the person with the condition
1. Improve dialogue and communication between people
with diabetes and healthcare professionals
DAWN call to action
The 2nd DAWN International Summit 5 November 2003, London, UK:
Practical Diabetes International, Volume 21, Issue 5, 2004
1
1. Improve team-based care of and communication among
healthcare professionals2
1. Increase delivery of individual support for more active
self-management and healthier lifestyle3
1. Overcome emotional barriers to effective therapy among
healthcare professionals and people with diabetes4
1. Enable healthcare professionals to assess and address
needs for psychological support and treatment among
people with diabetes
5
Why was a new study required?
1. International Diabetes Federation (IDF). IDF Diabetes Atlas, 6th edition revision, 2014.www.idf.org/diabetesatlas; 2. IDF
Diabetes Atlas, Fifth Edition, 2011 3. http://www.who.int/mediacentre/factsheets/fs312/en/index.html
387million
People with diabetes
today 1
Will increase to
592 million by 20352
10seconds
Three more people
will develop diabetes3
Every
Primary health systems are under-
resourced and poorly designed to
deliver empowering and supportive
preventive diabetes and chronic care
Active broad involvement of people with
diabetes and their family members, use
of chronic care models, and IT/mobile
technologies are yet to be fully realised
DAWN2 required to
provide new global evidence and a partnership
platform to drive long-term change for
person-centered chronic care and prevention
Society: A healthcare system,
government, and public that are
willing to listen, change, and be
supportive of my condition
Me: Being able to cope with my
condition, and living a full, healthy,
and productive life
Family and friends: Emotional
and practical support in all aspects
of my condition
Community:
Medical care and treatment: Access
to quality diagnosis, treatment, care,
and information
Work/school: Support for, and
understanding of, my condition
Living: Having the same opportunities
to enjoy life as everybody else
The DAWN™ needs model 2011. DAWN Study 2001
DAWN Youth Study 2008; DAWN2 Dialogue Events 2011
A new needs model for diabetes
The DAWN2 study
Long-term study goals
 Raise awareness of the unmet
needs of people with diabetes, their
family members, and healthcare
professionals
 Facilitate new dialogue and
collaboration among all key
stakeholders in diabetes to
improve patient involvement and
equal access to quality care,
self-management education,
and support
 Drive scientific benchmarking and
better practice sharing to facilitate
global, national, and local action for
person-centered diabetes care
To enable all people
with diabetes to live
full, healthy, and
productive lives, and be
actively engaged in
preserving their own
health and quality
of life
Unique elements
 A participatory process: from concept to action
 Building on a decade of DAWN insights worldwide
 Use of IDF, IAPO, and WHO models for person-centered
chronic care, rights, and responsibilities
 A 360º approach to explore also the needs of family
members and healthcare professionals
 Benchmarking person-centered diabetes care
 Benchmarking national policies for person-centered care
 Personal narratives of all stakeholder groups
IDF, International Diabetes Federation; IAPO, International Alliance of
Patients’ Organizations; WHO, World Health Organization
Objectives
Primary Outcome
 Assess potential barriers to and facilitators of active self-
management of diabetes among people with diabetes and their
family members and healthcare professionals
Secondary Outcomes
 Establish national benchmarks for health status, quality of life,
access to self-management education and to self-care in diabetes
 Assess the access to, and use and benefit of, support from
healthcare teams, family and friends, communities and society
 Explore and pinpoint the most important facilitators and barriers
to person-centered chronic care for each stakeholder group
 Identify successes, wishes, needs, preferences and priorities for
change for all stakeholders
Participating countries
Mexico
Netherlands
Poland
Russian Fed.
Spain
Turkey
UK
USA
Algeria
Canada
China
Denmark
France
Germany
India
Italy
Japan
Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
Key stakeholders identified for study
participation
 People with diabetes (≥18 years)
− Type 1
− Type 2
 Treated with insulin (Insulin Med)
 Treated with diabetes medication other than insulin (Non-Insulin Med)
 Not treated with any diabetes medication (Non-Med)
 Adult family members of adults with diabetes
 Healthcare professionals who treat people with diabetes
− Primary care/General practitioners (PCPs/GPs)
− Diabetes specialists
− Nurses/Educators
− Dieticians/Nutritionists
Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
Qualification criteria:
Healthcare professionals
Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
PCPs/GPs
• Primary specialty of
general practice or
internal medicine
• 5+ adult patients with
diabetes per month
• Initiate oral diabetes
medication
Specialists
• Primary specialty of
endocrinology,
diabetology, or general
practice/internal medicine
with sub-speciality in
diabetes
• 20->50 adult patients
with diabetes per month
(varies by country)
• Prescribe insulin for
diabetes
Nurses/Dieticians
• General practice and
diabetes nurses, nurse
practitioners, physician
assistants, dieticians,
and nutritionists
• 5+ adult patients with
diabetes per month
• Agree to participate upon review of the informed consent form provided
• Currently reside in each country
• Have been in practice/their profession for at least 1 year
All
participants
must
Specific criteria
Qualification criteria:
People with diabetes and family members
Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
• Diagnosed with diabetes by a
healthcare professional
• At least 12 months ago
• Not only during pregnancy
People with diabetes
• Not diagnosed with diabetes
• Live in the same household
with an adult 18+ years of
age with diabetes (not only
during pregnancy)
• Involved in the care of the
adult with diabetes
Family members
• Agree to participate upon review of the informed consent form provided
• Currently reside in each country
• Be 18+ years of age
All
participants
must
Specific criteria
Recruitment and interviewing process
Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
Identified from
 Online panels and databases
 Phone lists
 General population directories,
physician/hospital directories
 Referrals from participating people with
diabetes (family members only)
 Professional association lists (healthcare
professionals only)
Invited by
 Email
 Phone
 Hospital intercept
 In-person methods
Surveys conducted
 Online
 By phone (people with diabetes
and family members only)
 In-person (people with diabetes
and family members only)
Survey language
 Local language(s)
(except for India healthcare
professionals – English)
Data collection
Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
1. National geographic coverage was ensured for
the majority of the countries
Geographic
coverage
1. A wide range of socio-economic status was
ensured for people with diabetes and family
members
Demographic
representation
1. The surveys were conducted between
March and September 2012
Data collection
timing
Country sample quotas
GP, general practitioner; PCP, primary care physician
T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus
Total participants per country
n=900
People with diabetes
n=500
T1DM
n=80
T2DM (n=420)
-Insulin medicated (n=150)
-Non-insulin medicated (n=170)
-Non-medicated (n=100)
Family members
n=120
Healthcare professionals
n=280
PCPs/GPs
n=120
Diabetes specialists
n=80
Nurses/dietitians
n=80
Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
Total participants globally
n=15,438
People with diabetes1
n=8596
Type 1
n=1368
Type 2 (n= 7228)
-Insulin Med (n=2591)
-Non-Insulin Med (n=2937)
-Non-Med (n=1700)
Family members2
n=2057
Healthcare
professionals3
n=4785
PCPs/GPs
n=2066
Diabetes specialists
n=1350
Nurses
n=827
Dietitians
n=542
Total study population
1. Nicolucci A, et al. Diabet Med 2013;30:767–77; 2. Kovacs Burns K, et al. Diabet Med 2013;30:778–88
3. Holt R, et al. Diabet Med 2013;30:789–98
Questionnaire development
 Questionnaires developed by international multi-disciplinary
workgroup including people with diabetes
 Questionnaire based on person-centered model for
chronic care
 Questionnaires for each stakeholder group mirror each other
 Original DAWN study questions for evaluation of trends
 New questions for issues such as discrimination and
education
 Validated measures (and adaptations thereof) for the
purpose of cross-national and longitudinal
benchmarking
 Open-ended questions to capture individual stories
Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
Stuckey H, et al. ADA 2013, Chicago; Abstract 2013-A-4653
Questionnaire topics
Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
Attitudes and beliefs
about diabetes
Care and
support/involvement
Diabetes education
and information
Health/quality of life
(people with diabetes and
family members)
Diabetes profile
Active
self-management
Diabetes training
(healthcare professionals)
Future needs
Demographic and
practice characteristics
The first DAWN2™
benchmarking
results
Percentage of people concerned about
the risk of hypoglycemia by country
The dotted line represents the mean value relative to the entire sample of people with diabetes.
Nicolucci A, et al. Diabet Med 2013;30:767–77
Barriers to diabetes medications
People with
diabetes would be
willing to start
insulin if
recommended
Base: All qualified people with diabetes who currently receive meds other than insulin or other injectables or do not receive any diabetes
medications (variable base)
Q1458/Q1460 Please rate to what extent you agree with the following statements about diabetes medication based on your own experience or
knowledge/about diabetes treatment and medication. Scale of: fully disagree, mainly disagree, mainly agree, fully agree, not sure
A
People with diabetes
would be willing to start
injectables other than
insulin if recommended
B
AB
ABC
ABD
Starting insulin means
people with diabetes have
not followed treatment
recommendations properly
B AB
Risk of hypoglycaemia associated with insulin
Taking insulin increases the risk of low blood sugar
(% of people with diabetes on medication who mainly or fully agree)
Base: All qualified people with diabetes (Type 1: n=1,368; Type 2 Insulin users: n=2,591; Type 2 Non-Insulin users: n=2,937)
Q1458 Please rate to what extent you agree with the following statements about diabetes medications based on your own experience or
knowledge. Scale of: fully disagree, mainly disagree, mainly agree, fully agree, not sure
D
BD
Access to mental health professionals for
referral
A
ABD
A
% of health care professionals feeling there should be better
access to psychologists or psychiatrists for referral
(ratings of 5 or 6 on a 6-point agreement scale)
Base: All qualified health care professionals (PCPs/GPs: n=2,066; Specialists: n=1,350; Nurses: n=827; Dietitians: n=542)
Q955 Thinking generally about diabetes care in your country, please indicate the extent to which you agree or disagree
with each of the following statements. Scale of: fully disagree (1) to fully agree (6)
33%
43%
26%
49%
61%
36%
0% 100%
I prefer to delay the initiation of GLP-1
analogues until it is absolutely essential
I prefer to delay the initiation of
insulin until it is absolutely essential
I prefer to delay the initiation of oral
therapy until it is absolutely essential
PCPs/GPs (A) Specialists (B)
‘Fully/Mainly Agree’ Ratings
Attitudes about type 2 treatments
(Physicians)
Base: All Qualified Physicians (PCPs: n=2,066; Specialists: n=1,350)
Q1010 Please indicate the extent to which you agree or disagree with the following treatment approaches for Type 2 patients with diabetes.
B
B
B
48%
74%
72%
65%
68%
69%
87%
89%
43%
72%
65%
68%
60%
66%
78%
83%
0% 100%
Less pain or discomfort when taking medications
Greater effect on multiple risk factors for complications
Greater effect on lowering blood sugar
Fewer daily doses
Greater flexibility of dosing times to fit a patient's lifestyle
Fewer side effects (other than hypoglycemia and weight gain)
Less risk of weight gain
Less risk of hypoglycemia
PCPs/GPs (A) Specialists (B)
Improvements in diabetes medication
(Physicians)
Base: All Qualified Physicians (PCPs: n=2,066; Specialists: n=1,350)
Q1015 Please consider the treatments that are currently available. Which improvements in diabetes
medication would be most helpful for improving outcomes for your patients with diabetes?
Improvements Physicians Find Most Helpful To Achieve Better Patient Outcomes
Physicians could select more than one response
A
A
A
A
A
Summary
 The DAWN2 study is a multinational, multidisciplinary and multi-stakeholder
survey
− Conducted in 17 countries, on four continents, taking a 360° perspective
− Importantly, the study includes family members of people with diabetes
 Study goals are to:
− Achieve a broader humanistic and societal perspective on the burden of diabetes
− Provide a voice for people with diabetes and those caring for them, reflecting unmet
needs and new opportunities
− Identify areas for improvement and determine drivers of change towards person-
centred diabetes care
− Facilitate collaborative advocacy and action for the improvement of self-management
and psychosocial support and related aspects of diabetes care and prevention
 Findings from DAWN2 will impact on future research, clinical practice, and
public policy

More Related Content

What's hot

Management of glycemic variability- Role of DPP4i (1).pptx
Management of glycemic variability- Role of DPP4i (1).pptxManagement of glycemic variability- Role of DPP4i (1).pptx
Management of glycemic variability- Role of DPP4i (1).pptx
Dilip Moghe
 
Diabetes in World and Bangladesh
Diabetes in World and BangladeshDiabetes in World and Bangladesh
Diabetes in World and Bangladesh
MI Muhammad
 
Early Detection and Management of Diabetes by Dr Shahjada Selim
Early Detection and Management of Diabetes by Dr Shahjada SelimEarly Detection and Management of Diabetes by Dr Shahjada Selim
Early Detection and Management of Diabetes by Dr Shahjada Selim
Bangabandhu Sheikh Mujib Medical University
 
Jardiance- PresentationCopy
Jardiance- PresentationCopyJardiance- PresentationCopy
Jardiance- PresentationCopy
dannbetts
 
Depression+and+Diabetes
Depression+and+DiabetesDepression+and+Diabetes
Depression+and+Diabetes
dhavalshah4424
 
glyxambi
glyxambiglyxambi
Semaglutide journal club
Semaglutide journal clubSemaglutide journal club
Semaglutide journal club
Bhargav Kiran
 
Symptoms of Pre-Diabetes and Diabetes Prevention Tips
Symptoms of Pre-Diabetes and Diabetes Prevention TipsSymptoms of Pre-Diabetes and Diabetes Prevention Tips
Symptoms of Pre-Diabetes and Diabetes Prevention Tips
InovaHealth
 
NASHeDrBenlloch2022shared.pdf
NASHeDrBenlloch2022shared.pdfNASHeDrBenlloch2022shared.pdf
NASHeDrBenlloch2022shared.pdf
Salvador Benlloch Pérez
 
Controversies in type 2 diabetes mellitus
Controversies in type 2 diabetes mellitusControversies in type 2 diabetes mellitus
Controversies in type 2 diabetes mellitus
Pratap Tiwari
 
Januvia by shally bhardwaj
Januvia by shally bhardwajJanuvia by shally bhardwaj
Januvia by shally bhardwaj
shallybhardwaj
 
Drug for Treating Obesity
Drug for Treating ObesityDrug for Treating Obesity
Drug for Treating Obesity
Fara Dyba
 
SGLT2i
SGLT2iSGLT2i
SGLT2i
dibufolio
 
Tight Glycemic Control in the Prevention of Cardiovascular Disease
Tight Glycemic Control in the Prevention of Cardiovascular DiseaseTight Glycemic Control in the Prevention of Cardiovascular Disease
Tight Glycemic Control in the Prevention of Cardiovascular Disease
Iris Thiele Isip-Tan
 
Cfm_Presentation
Cfm_Presentation Cfm_Presentation
Cfm_Presentation
y_sudhakar
 
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...
PVI, PeerView Institute for Medical Education
 
Updates of Diabetes Management by Dr Selim
Updates of Diabetes Management by Dr SelimUpdates of Diabetes Management by Dr Selim
Updates of Diabetes Management by Dr Selim
Bangabandhu Sheikh Mujib Medical University
 
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 InhibitorsThe Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
PHAM HUU THAI
 
Hyperglycemia in Acute Stroke
Hyperglycemia in Acute Stroke Hyperglycemia in Acute Stroke
Hyperglycemia in Acute Stroke
Ade Wijaya
 
Insulin initiation adjustment by Dr Shahjada Selim
Insulin initiation adjustment by Dr Shahjada SelimInsulin initiation adjustment by Dr Shahjada Selim
Insulin initiation adjustment by Dr Shahjada Selim
Bangabandhu Sheikh Mujib Medical University
 

What's hot (20)

Management of glycemic variability- Role of DPP4i (1).pptx
Management of glycemic variability- Role of DPP4i (1).pptxManagement of glycemic variability- Role of DPP4i (1).pptx
Management of glycemic variability- Role of DPP4i (1).pptx
 
Diabetes in World and Bangladesh
Diabetes in World and BangladeshDiabetes in World and Bangladesh
Diabetes in World and Bangladesh
 
Early Detection and Management of Diabetes by Dr Shahjada Selim
Early Detection and Management of Diabetes by Dr Shahjada SelimEarly Detection and Management of Diabetes by Dr Shahjada Selim
Early Detection and Management of Diabetes by Dr Shahjada Selim
 
Jardiance- PresentationCopy
Jardiance- PresentationCopyJardiance- PresentationCopy
Jardiance- PresentationCopy
 
Depression+and+Diabetes
Depression+and+DiabetesDepression+and+Diabetes
Depression+and+Diabetes
 
glyxambi
glyxambiglyxambi
glyxambi
 
Semaglutide journal club
Semaglutide journal clubSemaglutide journal club
Semaglutide journal club
 
Symptoms of Pre-Diabetes and Diabetes Prevention Tips
Symptoms of Pre-Diabetes and Diabetes Prevention TipsSymptoms of Pre-Diabetes and Diabetes Prevention Tips
Symptoms of Pre-Diabetes and Diabetes Prevention Tips
 
NASHeDrBenlloch2022shared.pdf
NASHeDrBenlloch2022shared.pdfNASHeDrBenlloch2022shared.pdf
NASHeDrBenlloch2022shared.pdf
 
Controversies in type 2 diabetes mellitus
Controversies in type 2 diabetes mellitusControversies in type 2 diabetes mellitus
Controversies in type 2 diabetes mellitus
 
Januvia by shally bhardwaj
Januvia by shally bhardwajJanuvia by shally bhardwaj
Januvia by shally bhardwaj
 
Drug for Treating Obesity
Drug for Treating ObesityDrug for Treating Obesity
Drug for Treating Obesity
 
SGLT2i
SGLT2iSGLT2i
SGLT2i
 
Tight Glycemic Control in the Prevention of Cardiovascular Disease
Tight Glycemic Control in the Prevention of Cardiovascular DiseaseTight Glycemic Control in the Prevention of Cardiovascular Disease
Tight Glycemic Control in the Prevention of Cardiovascular Disease
 
Cfm_Presentation
Cfm_Presentation Cfm_Presentation
Cfm_Presentation
 
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...
The Role of SGLT2 Inhibitors in Type 2 Diabetes: CV, Metabolic, and Renal Con...
 
Updates of Diabetes Management by Dr Selim
Updates of Diabetes Management by Dr SelimUpdates of Diabetes Management by Dr Selim
Updates of Diabetes Management by Dr Selim
 
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 InhibitorsThe Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
 
Hyperglycemia in Acute Stroke
Hyperglycemia in Acute Stroke Hyperglycemia in Acute Stroke
Hyperglycemia in Acute Stroke
 
Insulin initiation adjustment by Dr Shahjada Selim
Insulin initiation adjustment by Dr Shahjada SelimInsulin initiation adjustment by Dr Shahjada Selim
Insulin initiation adjustment by Dr Shahjada Selim
 

Viewers also liked

Lec 1 nutrition therapy diabetes mellitus and physical activates
Lec 1 nutrition therapy diabetes mellitus and physical activatesLec 1 nutrition therapy diabetes mellitus and physical activates
Lec 1 nutrition therapy diabetes mellitus and physical activates
Siham Gritly
 
Diabetes Lecture
Diabetes LectureDiabetes Lecture
Diabetes Lecture
Jofred Martinez
 
Diabetesmellitus
DiabetesmellitusDiabetesmellitus
Diabetesmellitus
dariush Gholami
 
Diabetes mellitus an overview
Diabetes mellitus an overviewDiabetes mellitus an overview
Diabetes mellitus an overview
Ruth Nwokoma
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
Tosca Torres
 
Diabetes powerpoint
Diabetes powerpointDiabetes powerpoint
Diabetes powerpoint
mldanforth
 

Viewers also liked (6)

Lec 1 nutrition therapy diabetes mellitus and physical activates
Lec 1 nutrition therapy diabetes mellitus and physical activatesLec 1 nutrition therapy diabetes mellitus and physical activates
Lec 1 nutrition therapy diabetes mellitus and physical activates
 
Diabetes Lecture
Diabetes LectureDiabetes Lecture
Diabetes Lecture
 
Diabetesmellitus
DiabetesmellitusDiabetesmellitus
Diabetesmellitus
 
Diabetes mellitus an overview
Diabetes mellitus an overviewDiabetes mellitus an overview
Diabetes mellitus an overview
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Diabetes powerpoint
Diabetes powerpointDiabetes powerpoint
Diabetes powerpoint
 

Similar to The 2nd Diabetes Attitudes, Wishes & Needs (DAWN2) study: objectives and methodology

Dac presentation sue glass
Dac presentation   sue glassDac presentation   sue glass
Dac presentation sue glass
Brandon Williams
 
C12 uk evidence based nutrition guidelines 2011
C12 uk evidence based nutrition guidelines 2011C12 uk evidence based nutrition guidelines 2011
C12 uk evidence based nutrition guidelines 2011
Diabetes for all
 
Community and Public Health (Week 7)
Community and Public Health (Week 7)Community and Public Health (Week 7)
Community and Public Health (Week 7)
Ana Anastacio
 
C12 uk evidence based nutrition guidelines for the prevention and management ...
C12 uk evidence based nutrition guidelines for the prevention and management ...C12 uk evidence based nutrition guidelines for the prevention and management ...
C12 uk evidence based nutrition guidelines for the prevention and management ...
Diabetes for all
 
22 j cardio diabetesmetabdisord1118-4126632_112746
22 j cardio diabetesmetabdisord1118-4126632_11274622 j cardio diabetesmetabdisord1118-4126632_112746
22 j cardio diabetesmetabdisord1118-4126632_112746
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
Diabetes Manual_ a Guide to Diabetes Management.pdf
Diabetes Manual_ a Guide to Diabetes Management.pdfDiabetes Manual_ a Guide to Diabetes Management.pdf
Diabetes Manual_ a Guide to Diabetes Management.pdf
OrestesGomezG
 
Evidence based Practice
Evidence based PracticeEvidence based Practice
Evidence based Practice
Suyash Sharma
 
C14 idf diabetes in childhood and adolescence guidelines 2011
C14 idf diabetes in childhood and adolescence guidelines 2011C14 idf diabetes in childhood and adolescence guidelines 2011
C14 idf diabetes in childhood and adolescence guidelines 2011
Diabetes for all
 
Prof-Dennis-Yue-Kellion-Lecture.ppt
Prof-Dennis-Yue-Kellion-Lecture.pptProf-Dennis-Yue-Kellion-Lecture.ppt
Prof-Dennis-Yue-Kellion-Lecture.ppt
victorgolubev97
 
Ajp mrecs dsme
Ajp mrecs dsmeAjp mrecs dsme
Article information booklet on dm
Article information booklet on dmArticle information booklet on dm
Article information booklet on dm
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
Role of diabetes education
Role of diabetes educationRole of diabetes education
Role of diabetes education
Riyad Banayot
 
Knowledge, attitude, practice and associated factors
Knowledge, attitude, practice and associated factorsKnowledge, attitude, practice and associated factors
Knowledge, attitude, practice and associated factors
Beka Aberra
 
Working together to manage diabetes
Working together to manage diabetesWorking together to manage diabetes
Working together to manage diabetes
Online Marketing
 
Jude Stansfield
Jude StansfieldJude Stansfield
Jude Stansfield
theCALMzone
 
public health nursing
 public health nursing public health nursing
public health nursing
Kailash Nagar
 
Public Health Nursing introduction
Public Health Nursing introductionPublic Health Nursing introduction
Public Health Nursing introduction
Kailash Nagar
 
Strategies for reducing morbidity and mortality from diabetes through health
Strategies for reducing morbidity and mortality from diabetes through healthStrategies for reducing morbidity and mortality from diabetes through health
Strategies for reducing morbidity and mortality from diabetes through health
สปสช นครสวรรค์
 
Overview of tackling non-communicable diseases in England
Overview of tackling non-communicable diseases in EnglandOverview of tackling non-communicable diseases in England
Overview of tackling non-communicable diseases in England
Dr Justin Varney
 
Journal of Research in Diabetes & Metabolism
Journal of Research in Diabetes & MetabolismJournal of Research in Diabetes & Metabolism
Journal of Research in Diabetes & Metabolism
SciRes Literature LLC. | Open Access Journals
 

Similar to The 2nd Diabetes Attitudes, Wishes & Needs (DAWN2) study: objectives and methodology (20)

Dac presentation sue glass
Dac presentation   sue glassDac presentation   sue glass
Dac presentation sue glass
 
C12 uk evidence based nutrition guidelines 2011
C12 uk evidence based nutrition guidelines 2011C12 uk evidence based nutrition guidelines 2011
C12 uk evidence based nutrition guidelines 2011
 
Community and Public Health (Week 7)
Community and Public Health (Week 7)Community and Public Health (Week 7)
Community and Public Health (Week 7)
 
C12 uk evidence based nutrition guidelines for the prevention and management ...
C12 uk evidence based nutrition guidelines for the prevention and management ...C12 uk evidence based nutrition guidelines for the prevention and management ...
C12 uk evidence based nutrition guidelines for the prevention and management ...
 
22 j cardio diabetesmetabdisord1118-4126632_112746
22 j cardio diabetesmetabdisord1118-4126632_11274622 j cardio diabetesmetabdisord1118-4126632_112746
22 j cardio diabetesmetabdisord1118-4126632_112746
 
Diabetes Manual_ a Guide to Diabetes Management.pdf
Diabetes Manual_ a Guide to Diabetes Management.pdfDiabetes Manual_ a Guide to Diabetes Management.pdf
Diabetes Manual_ a Guide to Diabetes Management.pdf
 
Evidence based Practice
Evidence based PracticeEvidence based Practice
Evidence based Practice
 
C14 idf diabetes in childhood and adolescence guidelines 2011
C14 idf diabetes in childhood and adolescence guidelines 2011C14 idf diabetes in childhood and adolescence guidelines 2011
C14 idf diabetes in childhood and adolescence guidelines 2011
 
Prof-Dennis-Yue-Kellion-Lecture.ppt
Prof-Dennis-Yue-Kellion-Lecture.pptProf-Dennis-Yue-Kellion-Lecture.ppt
Prof-Dennis-Yue-Kellion-Lecture.ppt
 
Ajp mrecs dsme
Ajp mrecs dsmeAjp mrecs dsme
Ajp mrecs dsme
 
Article information booklet on dm
Article information booklet on dmArticle information booklet on dm
Article information booklet on dm
 
Role of diabetes education
Role of diabetes educationRole of diabetes education
Role of diabetes education
 
Knowledge, attitude, practice and associated factors
Knowledge, attitude, practice and associated factorsKnowledge, attitude, practice and associated factors
Knowledge, attitude, practice and associated factors
 
Working together to manage diabetes
Working together to manage diabetesWorking together to manage diabetes
Working together to manage diabetes
 
Jude Stansfield
Jude StansfieldJude Stansfield
Jude Stansfield
 
public health nursing
 public health nursing public health nursing
public health nursing
 
Public Health Nursing introduction
Public Health Nursing introductionPublic Health Nursing introduction
Public Health Nursing introduction
 
Strategies for reducing morbidity and mortality from diabetes through health
Strategies for reducing morbidity and mortality from diabetes through healthStrategies for reducing morbidity and mortality from diabetes through health
Strategies for reducing morbidity and mortality from diabetes through health
 
Overview of tackling non-communicable diseases in England
Overview of tackling non-communicable diseases in EnglandOverview of tackling non-communicable diseases in England
Overview of tackling non-communicable diseases in England
 
Journal of Research in Diabetes & Metabolism
Journal of Research in Diabetes & MetabolismJournal of Research in Diabetes & Metabolism
Journal of Research in Diabetes & Metabolism
 

More from Primary Care Diabetes Europe

The Clinical management of type 2 diabetes for the elderly
The Clinical management of type 2 diabetes for the elderlyThe Clinical management of type 2 diabetes for the elderly
The Clinical management of type 2 diabetes for the elderly
Primary Care Diabetes Europe
 
Elderly with Diabetes in Primary Care
Elderly with Diabetes in Primary CareElderly with Diabetes in Primary Care
Elderly with Diabetes in Primary Care
Primary Care Diabetes Europe
 
Diabetes Treatment and Cardiovascular Disease risk
Diabetes Treatment and Cardiovascular Disease riskDiabetes Treatment and Cardiovascular Disease risk
Diabetes Treatment and Cardiovascular Disease risk
Primary Care Diabetes Europe
 
Clinical management of elderly people with diabetes
Clinical management of elderly people with diabetesClinical management of elderly people with diabetes
Clinical management of elderly people with diabetes
Primary Care Diabetes Europe
 
Diabetes & Mental Health in primary care
Diabetes & Mental Health in primary careDiabetes & Mental Health in primary care
Diabetes & Mental Health in primary care
Primary Care Diabetes Europe
 
Psychosocial impact of diabetes
Psychosocial impact of diabetesPsychosocial impact of diabetes
Psychosocial impact of diabetes
Primary Care Diabetes Europe
 
Type 2 Diabetes and Cancer
Type 2 Diabetes and CancerType 2 Diabetes and Cancer
Type 2 Diabetes and Cancer
Primary Care Diabetes Europe
 
Treatment perceptions andmisunderstandings with cliniciansin people with diab...
Treatment perceptions andmisunderstandings with cliniciansin people with diab...Treatment perceptions andmisunderstandings with cliniciansin people with diab...
Treatment perceptions andmisunderstandings with cliniciansin people with diab...
Primary Care Diabetes Europe
 

More from Primary Care Diabetes Europe (8)

The Clinical management of type 2 diabetes for the elderly
The Clinical management of type 2 diabetes for the elderlyThe Clinical management of type 2 diabetes for the elderly
The Clinical management of type 2 diabetes for the elderly
 
Elderly with Diabetes in Primary Care
Elderly with Diabetes in Primary CareElderly with Diabetes in Primary Care
Elderly with Diabetes in Primary Care
 
Diabetes Treatment and Cardiovascular Disease risk
Diabetes Treatment and Cardiovascular Disease riskDiabetes Treatment and Cardiovascular Disease risk
Diabetes Treatment and Cardiovascular Disease risk
 
Clinical management of elderly people with diabetes
Clinical management of elderly people with diabetesClinical management of elderly people with diabetes
Clinical management of elderly people with diabetes
 
Diabetes & Mental Health in primary care
Diabetes & Mental Health in primary careDiabetes & Mental Health in primary care
Diabetes & Mental Health in primary care
 
Psychosocial impact of diabetes
Psychosocial impact of diabetesPsychosocial impact of diabetes
Psychosocial impact of diabetes
 
Type 2 Diabetes and Cancer
Type 2 Diabetes and CancerType 2 Diabetes and Cancer
Type 2 Diabetes and Cancer
 
Treatment perceptions andmisunderstandings with cliniciansin people with diab...
Treatment perceptions andmisunderstandings with cliniciansin people with diab...Treatment perceptions andmisunderstandings with cliniciansin people with diab...
Treatment perceptions andmisunderstandings with cliniciansin people with diab...
 

Recently uploaded

UNIT 2 Principles and Concept of Mental Health Nursing
UNIT 2 Principles and Concept of Mental Health NursingUNIT 2 Principles and Concept of Mental Health Nursing
UNIT 2 Principles and Concept of Mental Health Nursing
Prof. (Dr.) Rahul Sharma
 
Yoga talk & yoga slides by Flametree Yoga 11 July 2024.pdf
Yoga talk & yoga slides by Flametree Yoga 11 July 2024.pdfYoga talk & yoga slides by Flametree Yoga 11 July 2024.pdf
Yoga talk & yoga slides by Flametree Yoga 11 July 2024.pdf
Stuart McGill
 
Dr.Tarik Enaairi - Dermatology - Mastocytosis.ppsx
Dr.Tarik Enaairi - Dermatology - Mastocytosis.ppsxDr.Tarik Enaairi - Dermatology - Mastocytosis.ppsx
Dr.Tarik Enaairi - Dermatology - Mastocytosis.ppsx
Dr.Tarik Enaairi
 
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
CarriePoppy
 
Health communication, AI and health misinformation.pptx
Health communication, AI and health misinformation.pptxHealth communication, AI and health misinformation.pptx
Health communication, AI and health misinformation.pptx
Tina Purnat
 
Definition of Radiotherapy Treatment Planning.pptx
Definition of Radiotherapy Treatment Planning.pptxDefinition of Radiotherapy Treatment Planning.pptx
Definition of Radiotherapy Treatment Planning.pptx
Dr. Dheeraj Kumar
 
World Population Day 2024_Overview_Dr Bijan Das
World Population Day 2024_Overview_Dr Bijan DasWorld Population Day 2024_Overview_Dr Bijan Das
World Population Day 2024_Overview_Dr Bijan Das
srmnchatripura
 
Osvaldo Bernardo Muchanga- MALE CIRCUMCISION, ITS Vs SOCIOCULTURAL BELIEFS (C...
Osvaldo Bernardo Muchanga- MALE CIRCUMCISION, ITS Vs SOCIOCULTURAL BELIEFS (C...Osvaldo Bernardo Muchanga- MALE CIRCUMCISION, ITS Vs SOCIOCULTURAL BELIEFS (C...
Osvaldo Bernardo Muchanga- MALE CIRCUMCISION, ITS Vs SOCIOCULTURAL BELIEFS (C...
Osvaldo Bernardo Muchanga
 
Endocrine Physiology - Insulin and Glucagon
Endocrine Physiology -  Insulin and GlucagonEndocrine Physiology -  Insulin and Glucagon
Endocrine Physiology - Insulin and Glucagon
MedicoseAcademics
 
Rhythm Control in Atrial Fibrillation.pdf
Rhythm Control in Atrial Fibrillation.pdfRhythm Control in Atrial Fibrillation.pdf
Rhythm Control in Atrial Fibrillation.pdf
Jim Jacob Roy
 
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Internal medicine department, faculty of Medicine Beni-Suef University Egypt
 
Introduction to Dental Implant for undergraduate student
Introduction to Dental Implant for undergraduate studentIntroduction to Dental Implant for undergraduate student
Introduction to Dental Implant for undergraduate student
Shamsuddin Mahmud
 
Drugs Used in the Treatment of Arrhythmia
Drugs Used in the Treatment of ArrhythmiaDrugs Used in the Treatment of Arrhythmia
Drugs Used in the Treatment of Arrhythmia
Dr. Nikhilkumar Sakle
 
Hypothyroidism / Underactive thyroid gland presentation
Hypothyroidism / Underactive thyroid gland presentationHypothyroidism / Underactive thyroid gland presentation
Hypothyroidism / Underactive thyroid gland presentation
riyaramesh2003
 
Prakinsons disease and its affect on eye.
Prakinsons disease and its affect on eye.Prakinsons disease and its affect on eye.
Prakinsons disease and its affect on eye.
Riya Bist
 
Techniques and Principles of Cleaning and Shaping
Techniques and Principles of Cleaning and ShapingTechniques and Principles of Cleaning and Shaping
Techniques and Principles of Cleaning and Shaping
DheerajGupta915466
 
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential in...
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential in...Genetic deletion of HVEM in a leukemia B cell line promotes a preferential in...
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential in...
MARIALUISADELROGONZL
 
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 10, AVF and AVG - Complications (Diagnosis and Manageme...
Hemodialysis: Chapter 10, AVF and AVG - Complications (Diagnosis and Manageme...Hemodialysis: Chapter 10, AVF and AVG - Complications (Diagnosis and Manageme...
Hemodialysis: Chapter 10, AVF and AVG - Complications (Diagnosis and Manageme...
NephroTube - Dr.Gawad
 
Interpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac ArrhythmiasInterpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac Arrhythmias
MedicoseAcademics
 

Recently uploaded (20)

UNIT 2 Principles and Concept of Mental Health Nursing
UNIT 2 Principles and Concept of Mental Health NursingUNIT 2 Principles and Concept of Mental Health Nursing
UNIT 2 Principles and Concept of Mental Health Nursing
 
Yoga talk & yoga slides by Flametree Yoga 11 July 2024.pdf
Yoga talk & yoga slides by Flametree Yoga 11 July 2024.pdfYoga talk & yoga slides by Flametree Yoga 11 July 2024.pdf
Yoga talk & yoga slides by Flametree Yoga 11 July 2024.pdf
 
Dr.Tarik Enaairi - Dermatology - Mastocytosis.ppsx
Dr.Tarik Enaairi - Dermatology - Mastocytosis.ppsxDr.Tarik Enaairi - Dermatology - Mastocytosis.ppsx
Dr.Tarik Enaairi - Dermatology - Mastocytosis.ppsx
 
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
 
Health communication, AI and health misinformation.pptx
Health communication, AI and health misinformation.pptxHealth communication, AI and health misinformation.pptx
Health communication, AI and health misinformation.pptx
 
Definition of Radiotherapy Treatment Planning.pptx
Definition of Radiotherapy Treatment Planning.pptxDefinition of Radiotherapy Treatment Planning.pptx
Definition of Radiotherapy Treatment Planning.pptx
 
World Population Day 2024_Overview_Dr Bijan Das
World Population Day 2024_Overview_Dr Bijan DasWorld Population Day 2024_Overview_Dr Bijan Das
World Population Day 2024_Overview_Dr Bijan Das
 
Osvaldo Bernardo Muchanga- MALE CIRCUMCISION, ITS Vs SOCIOCULTURAL BELIEFS (C...
Osvaldo Bernardo Muchanga- MALE CIRCUMCISION, ITS Vs SOCIOCULTURAL BELIEFS (C...Osvaldo Bernardo Muchanga- MALE CIRCUMCISION, ITS Vs SOCIOCULTURAL BELIEFS (C...
Osvaldo Bernardo Muchanga- MALE CIRCUMCISION, ITS Vs SOCIOCULTURAL BELIEFS (C...
 
Endocrine Physiology - Insulin and Glucagon
Endocrine Physiology -  Insulin and GlucagonEndocrine Physiology -  Insulin and Glucagon
Endocrine Physiology - Insulin and Glucagon
 
Rhythm Control in Atrial Fibrillation.pdf
Rhythm Control in Atrial Fibrillation.pdfRhythm Control in Atrial Fibrillation.pdf
Rhythm Control in Atrial Fibrillation.pdf
 
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
 
Introduction to Dental Implant for undergraduate student
Introduction to Dental Implant for undergraduate studentIntroduction to Dental Implant for undergraduate student
Introduction to Dental Implant for undergraduate student
 
Drugs Used in the Treatment of Arrhythmia
Drugs Used in the Treatment of ArrhythmiaDrugs Used in the Treatment of Arrhythmia
Drugs Used in the Treatment of Arrhythmia
 
Hypothyroidism / Underactive thyroid gland presentation
Hypothyroidism / Underactive thyroid gland presentationHypothyroidism / Underactive thyroid gland presentation
Hypothyroidism / Underactive thyroid gland presentation
 
Prakinsons disease and its affect on eye.
Prakinsons disease and its affect on eye.Prakinsons disease and its affect on eye.
Prakinsons disease and its affect on eye.
 
Techniques and Principles of Cleaning and Shaping
Techniques and Principles of Cleaning and ShapingTechniques and Principles of Cleaning and Shaping
Techniques and Principles of Cleaning and Shaping
 
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential in...
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential in...Genetic deletion of HVEM in a leukemia B cell line promotes a preferential in...
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential in...
 
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
 
Hemodialysis: Chapter 10, AVF and AVG - Complications (Diagnosis and Manageme...
Hemodialysis: Chapter 10, AVF and AVG - Complications (Diagnosis and Manageme...Hemodialysis: Chapter 10, AVF and AVG - Complications (Diagnosis and Manageme...
Hemodialysis: Chapter 10, AVF and AVG - Complications (Diagnosis and Manageme...
 
Interpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac ArrhythmiasInterpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac Arrhythmias
 

The 2nd Diabetes Attitudes, Wishes & Needs (DAWN2) study: objectives and methodology

  • 1. The 2nd Diabetes Attitudes, Wishes & Needs (DAWN2) study: objectives and methodology Richard Holt University of Southampton, UK on behalf of the DAWN2 Study Group Rachid Malek, Johan Wens, João Eduardo Salles, Katharina Kovacs Burns, Michael Vallis, Xiaohui Guo, Ingrid Willaing, Gérard Reach, Norbert Hermanns, Bernhard Kulzer, Frans Pouwer, Antonio Nicolucci, Marco Comaschi, Hitoshi Ishii, Miguel Escalante, Andrzej Kokoszka, Alexandre Mayorov, Edelmiro Menendez, Ilhan Tarkun, Melanie Davies, Angus Forbes, Neil Munro, Mark Peyrot, Søren Eik Skovlund, & Christine Mullan-Jensen
  • 2. Richard Holt has acted as an advisory board member and speaker for Novo Nordisk, and as a speaker, for Sanofi- Aventis, Eli Lilly, Otsuka and Bristol-Myers Squibb. He has received grants in support of investigator trials from Novo Nordisk and has received funding for travel and accommodation to attend DAWN2 International Publication Planning Committee meetings and to attend this meeting
  • 3. DAWN study in 2001 5426 Adults with diabetes 13 Countries 3982 Healthcare professionals Platform for stakeholder dialogue and engagement To improve outcomes in diabetes, we must focus on the person with the condition
  • 4. 1. Improve dialogue and communication between people with diabetes and healthcare professionals DAWN call to action The 2nd DAWN International Summit 5 November 2003, London, UK: Practical Diabetes International, Volume 21, Issue 5, 2004 1 1. Improve team-based care of and communication among healthcare professionals2 1. Increase delivery of individual support for more active self-management and healthier lifestyle3 1. Overcome emotional barriers to effective therapy among healthcare professionals and people with diabetes4 1. Enable healthcare professionals to assess and address needs for psychological support and treatment among people with diabetes 5
  • 5. Why was a new study required? 1. International Diabetes Federation (IDF). IDF Diabetes Atlas, 6th edition revision, 2014.www.idf.org/diabetesatlas; 2. IDF Diabetes Atlas, Fifth Edition, 2011 3. http://www.who.int/mediacentre/factsheets/fs312/en/index.html 387million People with diabetes today 1 Will increase to 592 million by 20352 10seconds Three more people will develop diabetes3 Every Primary health systems are under- resourced and poorly designed to deliver empowering and supportive preventive diabetes and chronic care Active broad involvement of people with diabetes and their family members, use of chronic care models, and IT/mobile technologies are yet to be fully realised DAWN2 required to provide new global evidence and a partnership platform to drive long-term change for person-centered chronic care and prevention
  • 6. Society: A healthcare system, government, and public that are willing to listen, change, and be supportive of my condition Me: Being able to cope with my condition, and living a full, healthy, and productive life Family and friends: Emotional and practical support in all aspects of my condition Community: Medical care and treatment: Access to quality diagnosis, treatment, care, and information Work/school: Support for, and understanding of, my condition Living: Having the same opportunities to enjoy life as everybody else The DAWN™ needs model 2011. DAWN Study 2001 DAWN Youth Study 2008; DAWN2 Dialogue Events 2011 A new needs model for diabetes
  • 8. Long-term study goals  Raise awareness of the unmet needs of people with diabetes, their family members, and healthcare professionals  Facilitate new dialogue and collaboration among all key stakeholders in diabetes to improve patient involvement and equal access to quality care, self-management education, and support  Drive scientific benchmarking and better practice sharing to facilitate global, national, and local action for person-centered diabetes care To enable all people with diabetes to live full, healthy, and productive lives, and be actively engaged in preserving their own health and quality of life
  • 9. Unique elements  A participatory process: from concept to action  Building on a decade of DAWN insights worldwide  Use of IDF, IAPO, and WHO models for person-centered chronic care, rights, and responsibilities  A 360º approach to explore also the needs of family members and healthcare professionals  Benchmarking person-centered diabetes care  Benchmarking national policies for person-centered care  Personal narratives of all stakeholder groups IDF, International Diabetes Federation; IAPO, International Alliance of Patients’ Organizations; WHO, World Health Organization
  • 10. Objectives Primary Outcome  Assess potential barriers to and facilitators of active self- management of diabetes among people with diabetes and their family members and healthcare professionals Secondary Outcomes  Establish national benchmarks for health status, quality of life, access to self-management education and to self-care in diabetes  Assess the access to, and use and benefit of, support from healthcare teams, family and friends, communities and society  Explore and pinpoint the most important facilitators and barriers to person-centered chronic care for each stakeholder group  Identify successes, wishes, needs, preferences and priorities for change for all stakeholders
  • 12. Key stakeholders identified for study participation  People with diabetes (≥18 years) − Type 1 − Type 2  Treated with insulin (Insulin Med)  Treated with diabetes medication other than insulin (Non-Insulin Med)  Not treated with any diabetes medication (Non-Med)  Adult family members of adults with diabetes  Healthcare professionals who treat people with diabetes − Primary care/General practitioners (PCPs/GPs) − Diabetes specialists − Nurses/Educators − Dieticians/Nutritionists Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
  • 13. Qualification criteria: Healthcare professionals Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84 PCPs/GPs • Primary specialty of general practice or internal medicine • 5+ adult patients with diabetes per month • Initiate oral diabetes medication Specialists • Primary specialty of endocrinology, diabetology, or general practice/internal medicine with sub-speciality in diabetes • 20->50 adult patients with diabetes per month (varies by country) • Prescribe insulin for diabetes Nurses/Dieticians • General practice and diabetes nurses, nurse practitioners, physician assistants, dieticians, and nutritionists • 5+ adult patients with diabetes per month • Agree to participate upon review of the informed consent form provided • Currently reside in each country • Have been in practice/their profession for at least 1 year All participants must Specific criteria
  • 14. Qualification criteria: People with diabetes and family members Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84 • Diagnosed with diabetes by a healthcare professional • At least 12 months ago • Not only during pregnancy People with diabetes • Not diagnosed with diabetes • Live in the same household with an adult 18+ years of age with diabetes (not only during pregnancy) • Involved in the care of the adult with diabetes Family members • Agree to participate upon review of the informed consent form provided • Currently reside in each country • Be 18+ years of age All participants must Specific criteria
  • 15. Recruitment and interviewing process Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84 Identified from  Online panels and databases  Phone lists  General population directories, physician/hospital directories  Referrals from participating people with diabetes (family members only)  Professional association lists (healthcare professionals only) Invited by  Email  Phone  Hospital intercept  In-person methods Surveys conducted  Online  By phone (people with diabetes and family members only)  In-person (people with diabetes and family members only) Survey language  Local language(s) (except for India healthcare professionals – English)
  • 16. Data collection Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84 1. National geographic coverage was ensured for the majority of the countries Geographic coverage 1. A wide range of socio-economic status was ensured for people with diabetes and family members Demographic representation 1. The surveys were conducted between March and September 2012 Data collection timing
  • 17. Country sample quotas GP, general practitioner; PCP, primary care physician T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus Total participants per country n=900 People with diabetes n=500 T1DM n=80 T2DM (n=420) -Insulin medicated (n=150) -Non-insulin medicated (n=170) -Non-medicated (n=100) Family members n=120 Healthcare professionals n=280 PCPs/GPs n=120 Diabetes specialists n=80 Nurses/dietitians n=80 Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84
  • 18. Total participants globally n=15,438 People with diabetes1 n=8596 Type 1 n=1368 Type 2 (n= 7228) -Insulin Med (n=2591) -Non-Insulin Med (n=2937) -Non-Med (n=1700) Family members2 n=2057 Healthcare professionals3 n=4785 PCPs/GPs n=2066 Diabetes specialists n=1350 Nurses n=827 Dietitians n=542 Total study population 1. Nicolucci A, et al. Diabet Med 2013;30:767–77; 2. Kovacs Burns K, et al. Diabet Med 2013;30:778–88 3. Holt R, et al. Diabet Med 2013;30:789–98
  • 19. Questionnaire development  Questionnaires developed by international multi-disciplinary workgroup including people with diabetes  Questionnaire based on person-centered model for chronic care  Questionnaires for each stakeholder group mirror each other  Original DAWN study questions for evaluation of trends  New questions for issues such as discrimination and education  Validated measures (and adaptations thereof) for the purpose of cross-national and longitudinal benchmarking  Open-ended questions to capture individual stories Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84 Stuckey H, et al. ADA 2013, Chicago; Abstract 2013-A-4653
  • 20. Questionnaire topics Peyrot M, et al. Diabetes Res Clin Pract. 2013;99:174–84 Attitudes and beliefs about diabetes Care and support/involvement Diabetes education and information Health/quality of life (people with diabetes and family members) Diabetes profile Active self-management Diabetes training (healthcare professionals) Future needs Demographic and practice characteristics
  • 22. Percentage of people concerned about the risk of hypoglycemia by country The dotted line represents the mean value relative to the entire sample of people with diabetes. Nicolucci A, et al. Diabet Med 2013;30:767–77
  • 23. Barriers to diabetes medications People with diabetes would be willing to start insulin if recommended Base: All qualified people with diabetes who currently receive meds other than insulin or other injectables or do not receive any diabetes medications (variable base) Q1458/Q1460 Please rate to what extent you agree with the following statements about diabetes medication based on your own experience or knowledge/about diabetes treatment and medication. Scale of: fully disagree, mainly disagree, mainly agree, fully agree, not sure A People with diabetes would be willing to start injectables other than insulin if recommended B AB ABC ABD Starting insulin means people with diabetes have not followed treatment recommendations properly B AB
  • 24. Risk of hypoglycaemia associated with insulin Taking insulin increases the risk of low blood sugar (% of people with diabetes on medication who mainly or fully agree) Base: All qualified people with diabetes (Type 1: n=1,368; Type 2 Insulin users: n=2,591; Type 2 Non-Insulin users: n=2,937) Q1458 Please rate to what extent you agree with the following statements about diabetes medications based on your own experience or knowledge. Scale of: fully disagree, mainly disagree, mainly agree, fully agree, not sure D BD
  • 25. Access to mental health professionals for referral A ABD A % of health care professionals feeling there should be better access to psychologists or psychiatrists for referral (ratings of 5 or 6 on a 6-point agreement scale) Base: All qualified health care professionals (PCPs/GPs: n=2,066; Specialists: n=1,350; Nurses: n=827; Dietitians: n=542) Q955 Thinking generally about diabetes care in your country, please indicate the extent to which you agree or disagree with each of the following statements. Scale of: fully disagree (1) to fully agree (6)
  • 26. 33% 43% 26% 49% 61% 36% 0% 100% I prefer to delay the initiation of GLP-1 analogues until it is absolutely essential I prefer to delay the initiation of insulin until it is absolutely essential I prefer to delay the initiation of oral therapy until it is absolutely essential PCPs/GPs (A) Specialists (B) ‘Fully/Mainly Agree’ Ratings Attitudes about type 2 treatments (Physicians) Base: All Qualified Physicians (PCPs: n=2,066; Specialists: n=1,350) Q1010 Please indicate the extent to which you agree or disagree with the following treatment approaches for Type 2 patients with diabetes. B B B
  • 27. 48% 74% 72% 65% 68% 69% 87% 89% 43% 72% 65% 68% 60% 66% 78% 83% 0% 100% Less pain or discomfort when taking medications Greater effect on multiple risk factors for complications Greater effect on lowering blood sugar Fewer daily doses Greater flexibility of dosing times to fit a patient's lifestyle Fewer side effects (other than hypoglycemia and weight gain) Less risk of weight gain Less risk of hypoglycemia PCPs/GPs (A) Specialists (B) Improvements in diabetes medication (Physicians) Base: All Qualified Physicians (PCPs: n=2,066; Specialists: n=1,350) Q1015 Please consider the treatments that are currently available. Which improvements in diabetes medication would be most helpful for improving outcomes for your patients with diabetes? Improvements Physicians Find Most Helpful To Achieve Better Patient Outcomes Physicians could select more than one response A A A A A
  • 28. Summary  The DAWN2 study is a multinational, multidisciplinary and multi-stakeholder survey − Conducted in 17 countries, on four continents, taking a 360° perspective − Importantly, the study includes family members of people with diabetes  Study goals are to: − Achieve a broader humanistic and societal perspective on the burden of diabetes − Provide a voice for people with diabetes and those caring for them, reflecting unmet needs and new opportunities − Identify areas for improvement and determine drivers of change towards person- centred diabetes care − Facilitate collaborative advocacy and action for the improvement of self-management and psychosocial support and related aspects of diabetes care and prevention  Findings from DAWN2 will impact on future research, clinical practice, and public policy